Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| But I believe that this complementary product is the best in the market as far as the hand free category |
| Moreover, we keep our gross margin the highest in the industry, strong and steady at 84% for both Q4 and the full year, all while maintaining our established price structure for the platforms and for the consumable |
| Once again, we ended the quarter with a strong balance sheet |
| And we have improved dramatically the performance of the Morpheus8, which is, as everybody know, one of the biggest brand name in the medical aesthetic |
| Non-GAAP gross margins remained the highest in the industry and within our target range at 84% for both the fourth quarter and the full year of 2023 |
| The second quarter is also strong, and the first quarter is in between |
| As I said before, the Board of Directors decided not to do buyback because of many reasons that I have explained before, but rather to keep the money to try to do M&A, more strategic M&A, which we believe will benefit the company much better than buying our own stock |
| And then you obviously have a very strong balance sheet |
| As Moshe mentioned, we are pleased with the successful launches of Envision and Define |
| However, we are pleased to have grown our full year revenue to a record of $492 million, reflecting an 8% increase compared to the full year of 2021 |
| We have developed a very unique and very, I would say, breakthrough technology for new minimal invasive to be able to do plastic surgery with one incision point with revolutionary hand pieces |
| We take pride in being the only company in the industry that consistently generate over $100 million per quarter, demonstrating growth even in the face of a challenging year |
| So we're very, very encouraged, very, very encouraged |
| Both platforms have made significant progress in North America, gaining traction amongst practices and patients |
| As regard to the Define, as you know, the first generation of the Define was the Evoke which was very successful when it was introduced during the COVID time because it enabled the doctor to do social distancing treatment without being in the room |
| If we look back at '23, obviously, the first half of '23 was still a very solid year, especially in the first quarter, but both quarters were solid |
| We introduced all this during the sales meeting of North America in the beginning of - at the end of January, and it was well accepted |
| We intend to bring some doctors from the United States and Canada who are luminary for us in this particular category, ophthalmology and bring them to do workshop in Europe so we can expedite the penetration process, but we're very encouraged with Envision |
| We are encouraged by the results from the soft launch of our Envision platforms last year, and we expect Envision to expand outside the U.S |
| InMode continue to innovate, bringing new and exciting products to the market |
| We see that the doctors and the users are happy with the results |
| I hope 2024 will be a better year for us |
| For full year 2023, revenue totaled a record $492 million, an increase of 8% compared to 2022 |
| And everybody was excited |
| We will help to using our strong balance sheet, as Yair said and I said to help the leasing company or share the risk with them to expedite the process of clearing transaction for the doctors |
| Among our global contributors, Asia and Europe were the primary drivers fueling our growth rate |
| So the only thing that we can say is we expect some improvement in the situation of the macro look sometime in the second half of the year, not in the first year of the year |
| And the first half of 2023 was with the right momentum |
| The fourth quarter is the strongest one |
| Additionally, capitalizing on this lower year and our robust balance sheet, in 2023, we expanded our R&D activity by hiring more engineers and recruiting training professional |
| Statement |
|---|
| This resulted in 5% year-over-year decline in Q4 revenue, which amounted to $126.8 million |
| The second half of 2023 presented challenges for InMode for their aesthetic industry as all and to the aesthetic -- and to the surgical aesthetic sector in particular |
| This macroeconomic environment has also affected patients who are more sensitive to the price of the aesthetic treatment, resulting in lower underlying demand for our minimally invasive treatment |
| But as we mentioned, there is also some slowdown in the demand in the underlying market |
| In the fourth quarter, we revised our guidance for the first time in the history of the company due to the increased impact of the industry slowdown |
| It's a slowdown of the rate of growth |
| So with this - as Moshe mentioned, we do see some slowdown in the growth rate |
| So in the second half of the year, we start seeing some slowdown in the growth rate |
| We see some slowdown, not just in the equipment sales, but also we see some slowdown in the disposable sales because we believe that the slowdown affect the consumer as well and less people are going right now to do minimal invasive procedures, which is a little bit more effective than non-invasive procedure these days |
| So if I put all that kind of in the mix, it would seem to me that it's just a logical statement to say the first half of the year, probably down mid to upper single digits on a year-over-year basis from a revenue perspective |
| As everybody knows, we are facing a very challenging time in Israel |
| And as you noticed, they went down in the second half of the year, they did not report the second half, but in the first half of the year, they went down |
| Considering the anticipated slower market demand this year, we've implemented changes within our sales team in North America |
| The third quarter is the slowest one because of the summer |
| Although 2023 was not - I don't want to say that it was a tough year, but not a bad year |
| We're not doing cost cutting |
| But I'm sure you'll see that they did not grow this year |
| So it's in the high teens, but it's definitely lower than 40% - 40% that we saw in the first half of the year |
| On the opposite, they went down |
| Just curious, I know, Moshe, you mentioned January so far you haven't seen an improvement |
Please consider a small donation if you think this website provides you with relevant information